Daiichi Sankyo Company, Limited has received the FDA approval for SAVAYSA tablets, an oral, once-daily selective factor Xa-inhibitor, for reduction of stroke risk in non-valvular atrial fibrillation, or NVAF, and for the treatment of venous ... Individual.com, 1 week ago
New and Generic Drug Approvals: Savaysa - U.S. Food and Drug Administration, 2 weeks ago
U.S. FDA Approves Daiichi Sankyo's Once-Daily SAVAYSA (edoxaban) Tablets for Reduction of Stroke Risk in Non-Valvular Atrial Fibrillation and for the Treatment of Venous Thromboembolism - Pharmacy Choice, 1 week ago
Daiichi Sankyo will pay the federal government $39 million to resolve allegations it used lavish dinners and other kickbacks to persuade physicians to prescribe more of the company's drugs. A whistleblower lawsuit filed by a former Daiichi Sankyo ...FDA News, 1 week ago DAIICHI SANKYO : Announces Civil Settlement 4 Traders, 1 week ago Daiichi-Sankyo pays $39m to settle allegations Pharmafocus, 2 weeks ago New Jersey Pharmaceutical Company Agrees to Pay $39 Million to Settle Alleged Anti-Kickback Violations National Law Review, 1 week ago
Daiichi Sankyo Company, Limited has launched a new formulation of LIXIANA 60mg Tablets, or edoxaban, in Japan for the recently approved indications of the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial ...Individual.com, 1 month ago DAIICHI SANKYO : American Regent's Injectafer® ferric carboxymaltose injection Assigned J Code by Centers for Medicare & Medicaid Services 4 Traders, 1 month ago DAIICHI SANKYO : Launches New Formulation of LIXIANA® 60 mg Tablets edoxaban in Japan 4 Traders, 1 month ago
(MarketLine via COMTEX News Network) -- Daiichi Sankyo Company, Limited has announced that its generics subsidiary, Daiichi Sankyo Espha, has launched Levofloxacin Tablets DSEP 250mg, 500mg and Granules 10% whose therapeutic category is ...PredictWallStreet, 3 weeks ago
Daiichi Sankyo Company, Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its ...MarketResearch.com, 1 month ago
Nolan Auerbach & White reported the successful resolution of its client's five-year-long civil False Claims Act case against Daiichi Sankyo. According to a company release, the qui tam case was brought in March 2010 by client Kathy Fragoules, a ...Individual.com, 1 week ago DAIICHI SANKYO : Nolan Auerbach & White Resolves Daiichi Sankyo Whistleblower Case 4 Traders, 1 week ago Daiichi Sankyo Whistleblower Case Returns Over $39 Million to the Government Yahoo! Finance, 2 weeks ago
This is the first acquisition of the Singh brothers after they sold Ranbaxy to Daiichi Sankyo. Ranbaxy Group promoted Fortis Healthworld has acquired 90 percent stake in CRS Health, a Delhi-based pharma and wellness retail chain for Rs 15 crore, ...VC Circle, 1 month ago
DAIICHI SANKYO : Patent Application Titled "Tablet, Method of Producing Tablet, Tablet Management Device, Tablet Verification Device and Program Storage Medium"...
Patent Application Titled "Tablet, Method of Producing Tablet, Tablet Management Device, Tablet Verification Device and Program Storage Medium" Published Online By a News Reporter-Staff News Editor at Politics & Government Week -- According to ...4 Traders, 2 days ago
By a News Reporter-Staff News Editor at Pharma Business Week -- A patent by the inventor Yanagihara, Shigeo ( Tokyo , JP), filed on April 27, 2010 , was published online on January 13, 2015 , according to news reporting originating from Alexandria, ...4 Traders, 2 days ago Patent Issued for Crystals of Substituted Cycloalkene Derivatives 4 Traders, 2 days ago
DAIICHI SANKYO : Plexxikon and QuantumLeap Healthcare Collaborative Select PLX3397 for I-SPY 2 Trial in Breast Cancer
Plexxikon and QuantumLeap Healthcare Collaborative said that Plexxikon's drug candidate, PLX3397, has been selected for study in the I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular ...4 Traders, 1 month ago
on your WebpageAdd Widget >Get your members hooked!